These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21999266)

  • 1. Promoting justice in stem cell intellectual property.
    Regenberg A; Mathews DJ
    Regen Med; 2011 Nov; 6(6 Suppl):79-84. PubMed ID: 21999266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries.
    Andanda PA
    J Med Ethics; 2008 Mar; 34(3):171-9. PubMed ID: 18316458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needed: a new system of intellectual property rights.
    Thurow LC
    Harv Bus Rev; 1997; 75(5):94-103. PubMed ID: 10170334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opening stem cell research and development: a policy proposal for the management of data, intellectual property, and ethics.
    Winickoff DE; Saha K; Graff GD
    Yale J Health Policy Law Ethics; 2009; 9(1):52-127. PubMed ID: 19388486
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent prosecution strategies for stem cell related applications.
    Kumar R; Yeh JJ; Fernandez D; Hansen N
    J Biomol Screen; 2007 Sep; 12(6):769-74. PubMed ID: 17848639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of intellectual property rights on health care in Canada.
    Penner MD; Abouali A
    Health Law Can; 2008 Jun; 28(3-4):89-101. PubMed ID: 19051969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to intellectual property rights for investigators in health research and institutional intellectual property policy.
    Shemdoe GS
    Acta Trop; 2009 Nov; 112 Suppl 1():S80-3. PubMed ID: 19682967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual property. Enhanced: intellectual property landscape of the human genome.
    Jensen K; Murray F
    Science; 2005 Oct; 310(5746):239-40. PubMed ID: 16224006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intellectual property rights and right of access to medicines].
    Velásquez G
    Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patents or patients? Global access to pharmaceuticals and social justice.
    de Wildt G; Khoon CC
    Med Confl Surviv; 2008; 24 Suppl 1():S52-61. PubMed ID: 18771195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The paths around stem cell intellectual property.
    Taymor KS; Scott CT; Greely HT
    Nat Biotechnol; 2006 Apr; 24(4):411-3. PubMed ID: 16601720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
    Cohen-Kohler JC; Forman L; Lipkus N
    Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can you shrinkwrap a cow? Protections available for the intellectual property of the animal breeding industry.
    Ogden ER; Weigel K
    Anim Genet; 2007 Dec; 38(6):647-54. PubMed ID: 18052941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intellectual property conundrum for the biological sciences.
    Olds JL
    Anat Rec B New Anat; 2004 Mar; 277(1):5-9. PubMed ID: 15052648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patenting human pluripotent cells: balancing commercial, academic and ethical interests.
    Bahadur G; Morrison M
    Hum Reprod; 2010 Jan; 25(1):14-21. PubMed ID: 19897856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intellectual property and patent in stem cell research era.
    Kiatpongsan S
    J Med Assoc Thai; 2006 Nov; 89(11):1984-6. PubMed ID: 17205886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearing a path through the patent thicket.
    Holman C
    Cell; 2006 May; 125(4):629-33. PubMed ID: 16713553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Federal funding of human embryo stem cell research: advocating a broader approach.
    Braswell JR
    Chic Kent Law Rev; 2003; 78(1):423-43. PubMed ID: 15156895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.